A Trial of Preoperative MM-121 With Paclitaxel in HER2-negative Breast Cancer

Clinical trial NCT01421472 · COMPLETED

Trial details

NCT number: NCT01421472
Sponsor: Merrimack Pharmaceuticals
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

ER Positive, Her2 Negative Breast Cancer Patients Triple Negative Breast Cancer Patients

Start date: 2011-08-01
Primary completion: 2013-12-01
Enrollment: 196

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.